S
RUBY

SignatureFD’s Rubius Therapeutics, Inc RUBY Stock Holding History

SignatureFD’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,119
Closed -$6K – 3425
2022
Q1 		$6K Buy
1,119
+897
+404% +$5.7K ﹤0.01% 2450
2021
Q4 		$2K Hold
222
– – ﹤0.01% 2835
2021
Q3 		$4K Hold
222
– – ﹤0.01% 2481
2021
Q2 		$5K Hold
222
– – ﹤0.01% 2319
2021
Q1 		$6K Hold
222
– – ﹤0.01% 2103
2020
Q4 		$2K Buy
+222
New +$1.32K ﹤0.01% 2346
2020
Q2 		– Sell
-112
Closed – – 2718
2020
Q1 		$0 Hold
112
– – ﹤0.01% 2523
2019
Q4 		$1K Buy
+112
New +$1.08K ﹤0.01% 2147

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SignatureFD's RUBY Position: Q2 2022 in Review

SignatureFD sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2022, closing a stake of 1,119 shares — an estimated $6K sold.

SignatureFD first reported a position in RUBY in Q4 2019 and held it in 8 quarters. The position peaked at $6K in Q1 2022. 72 funds tracked by Wall St. Rank hold RUBY as of Q2 2022.

  • SignatureFD reported no remaining Rubius Therapeutics, Inc position as of Q2 2022 after selling out during the quarter.
  • SignatureFD sold 1,119 Rubius Therapeutics, Inc shares in Q2 2022, an estimated $6K.
  • SignatureFD first reported a position in Rubius Therapeutics, Inc in Q4 2019 and held it in 8 quarters.
  • SignatureFD's Rubius Therapeutics, Inc position peaked at $6K in Q1 2022.
  • 72 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2022.

Based on SignatureFD's 13F filing for Q2 2022, filed 10 Aug 2022.